The international COVID-19 vaccine sharing initiative called Covax has asked the World Health Organisation (WHO) to expedite the approval for Hyderabad-based Bharat Biotech’s Covaxin which is the first indigenously developed Indian vaccine against COVID-19, reports Economic Times.
In a meeting held on Friday (21 May), Covax facility experts from India and other nations recommended the approval of Covaxin and Russia's Sputnik V. This gains significance as WHO’s approval is a prerequisite for any COVID-19 vaccine to be included under the Covax for distribution.
It should be noted that so far, the WHO has only given approvals to the vaccines from Europe and North America.
Also, in a meeting yesterday (24 May), External Affairs Secretary Harsh Vardhan Shringla is said to have assured Bharat Biotech of the “fullest support” of diplomatic establishment in securing the approvals from the WHO and important countries.
Dr Krishna Ella led company had submitted its expression of interest for an emergency use listing (EUL) of Covaxin to WHO in April. Following this, the WHO had asked Bharat Biotech for additional details. The company is expected to submit its final dossier of details soon.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.